Strs Ohio Cuts Holdings in National Health Investors, Inc. $NHI

Strs Ohio decreased its stake in National Health Investors, Inc. (NYSE:NHI) by 31.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 76,700 shares of the real estate investment trust’s stock after selling 35,700 shares during the period. Strs Ohio’s holdings in National Health Investors were worth $6,202,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. International Assets Investment Management LLC bought a new stake in shares of National Health Investors during the 4th quarter worth $27,000. EverSource Wealth Advisors LLC increased its stake in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new position in National Health Investors in the fourth quarter valued at $33,000. GAMMA Investing LLC raised its position in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares in the last quarter. Finally, Key Capital Management INC purchased a new stake in National Health Investors during the fourth quarter valued at about $47,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft dropped their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. BMO Capital Markets decreased their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Truist Financial dropped their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Wells Fargo & Company cut their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Finally, Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $83.86.

National Health Investors Stock Down 0.1%

Shares of NYSE:NHI opened at $77.44 on Monday. The stock’s 50-day moving average price is $74.27 and its 200-day moving average price is $79.64. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The stock has a market capitalization of $3.75 billion, a P/E ratio of 24.98, a price-to-earnings-growth ratio of 3.48 and a beta of 0.51. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.8%. National Health Investors’s dividend payout ratio is currently 118.71%.

Insider Activity at National Health Investors

In related news, CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction on Friday, June 5th. The stock was purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were bought at an average cost of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by company insiders.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.